These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 3497984

  • 1. Xyloside inhibits synthesis of the class II-associated chondroitin sulfate proteoglycan and antigen presentation events.
    Rosamond S, Brown L, Gomez C, Braciale TJ, Schwartz BD.
    J Immunol; 1987 Sep 15; 139(6):1946-51. PubMed ID: 3497984
    [Abstract] [Full Text] [Related]

  • 2. Biosynthetic relationships of the chondroitin sulfate proteoglycan with Ia and invariant chain glycoproteins.
    Sant AJ, Cullen SE, Schwartz BD.
    J Immunol; 1985 Jul 15; 135(1):416-22. PubMed ID: 3858382
    [Abstract] [Full Text] [Related]

  • 3. Chondroitin sulphate proteoglycan production by NK cells and T cells: effects of xylosides on proliferation and cytotoxic function.
    Christmas SE, Steward WP, Lyon M, Gallagher JT, Moore M.
    Immunology; 1988 Feb 15; 63(2):225-31. PubMed ID: 3258273
    [Abstract] [Full Text] [Related]

  • 4. Xyloside-induced disruption of interphotoreceptor matrix proteoglycans results in retinal detachment.
    Lazarus HS, Hageman GS.
    Invest Ophthalmol Vis Sci; 1992 Feb 15; 33(2):364-76. PubMed ID: 1740367
    [Abstract] [Full Text] [Related]

  • 5. Cellular distribution of the Ia-associated chondroitin sulfate proteoglycan.
    Sant AJ, Schwartz BD, Cullen SE.
    J Immunol; 1985 Jul 15; 135(1):408-15. PubMed ID: 3923108
    [Abstract] [Full Text] [Related]

  • 6. Response of stratified cultures of human keratinocytes to disruption of proteoglycan synthesis by p-nitrophenyl-beta-D-xylopyranoside.
    Haggerty JG, Bretton RH, Milstone LM.
    J Cell Physiol; 1994 Jan 15; 158(1):39-46. PubMed ID: 8263027
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of proteoglycan synthesis eliminates the proteoglycan form of Ia-associated invariant chain and depresses antigen presentation.
    Sivak LE, Harris MR, Kindle C, Cullen SE.
    J Immunol; 1987 Mar 01; 138(5):1319-21. PubMed ID: 3468174
    [No Abstract] [Full Text] [Related]

  • 8. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    Pinet V, Malnati MS, Long EO.
    J Immunol; 1994 May 15; 152(10):4852-60. PubMed ID: 8176208
    [Abstract] [Full Text] [Related]

  • 9. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain.
    Battegay M, Bachmann MF, Burhkart C, Viville S, Benoist C, Mathis D, Hengartner H, Zinkernagel RM.
    Cell Immunol; 1996 Jan 10; 167(1):115-21. PubMed ID: 8548834
    [Abstract] [Full Text] [Related]

  • 10. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM, Rowell JF, Soloski MJ, Machamer CE, Siliciano RF.
    J Immunol; 1993 Sep 15; 151(6):2928-42. PubMed ID: 8376762
    [Abstract] [Full Text] [Related]

  • 11. Chondroitin sulphate proteoglycan is involved in lens vesicle morphogenesis in chick embryos.
    Gato A, Martin C, Alonso MI, Martinez-Alvarez C, Moro JA.
    Exp Eye Res; 2001 Oct 15; 73(4):469-78. PubMed ID: 11825019
    [Abstract] [Full Text] [Related]

  • 12. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M, Eisenlohr LC, Otvos L, Horowitz D, Yewdell JW, Bennink JR, Hackett CJ.
    Virology; 1994 May 15; 201(1):86-94. PubMed ID: 7513927
    [Abstract] [Full Text] [Related]

  • 13. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B, Katz J.
    J Immunol; 1985 Sep 15; 135(3):1616-23. PubMed ID: 3874903
    [Abstract] [Full Text] [Related]

  • 14. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
    Kirschfink M, Blase L, Engelmann S, Schwartz-Albiez R.
    J Immunol; 1997 Feb 01; 158(3):1324-31. PubMed ID: 9013976
    [Abstract] [Full Text] [Related]

  • 15. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
    Tite JP, Sloan A, Janeway CA.
    J Mol Cell Immunol; 1986 Feb 01; 2(4):179-90. PubMed ID: 3509916
    [Abstract] [Full Text] [Related]

  • 16. Intracellular features of type II procollagen and chondroitin sulfate proteoglycan synthesis in chondrocytes.
    Vertel BM, Barkman LL, Morrell JJ.
    J Cell Biochem; 1985 Feb 01; 27(3):215-29. PubMed ID: 3886677
    [Abstract] [Full Text] [Related]

  • 17. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z, Hofgaard PO, Omholt H, Bogen B.
    Scand J Immunol; 2004 Feb 01; 60(1-2):143-52. PubMed ID: 15238083
    [Abstract] [Full Text] [Related]

  • 18. Chondroitin sulfate proteoglycan with neurite-inhibiting activity is up-regulated following peripheral nerve injury.
    Zuo J, Hernandez YJ, Muir D.
    J Neurobiol; 1998 Jan 01; 34(1):41-54. PubMed ID: 9469617
    [Abstract] [Full Text] [Related]

  • 19. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH, Lien LL, Benacerraf B, Rock KL.
    J Immunol; 1993 May 15; 150(10):4206-17. PubMed ID: 8482833
    [Abstract] [Full Text] [Related]

  • 20. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S, Bertolino P, Deng H, Gerlier D, Rabourdin-Combe C.
    Immunology; 1993 Dec 15; 80(4):566-73. PubMed ID: 7508420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.